RNS Number : 9171Z Renalytix PLC 17 January 2024     Renalytix plc ("Renalytix" or the "Company")   Update on kidneyIntelX.dkd Local Coverage Determination Consideration   Local Coverage Determination would result in   contracted coverage for an estimated additional five million Medicare patients  

RNS Number : 1665Z Renalytix PLC 10 January 2024     Renalytix plc ("Renalytix" or the "Company")   New published data for   KidneyIntelX™   New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease   Electronic health record deployment of

RNS Number : 0685X Renalytix PLC 18 December 2023   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   December 18, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of the Company's convertible bond and the

RNS Number : 0572X Renalytix PLC 15 December 2023   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 15 December 2023   - Renalytix (NASDAQ: RNLX)  (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical

RNS Number : 2472W Renalytix PLC 08 December 2023   Renalytix plc ("Renalytix" or the "Company")   Directorate Change   LONDON and SALT LAKE CITY -   December 8, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on

RNS Number : 3917U Renalytix PLC 23 November 2023   Renalytix plc ("Renalytix" or the "Company")   Grant of Share Options   LONDON and SALT LAKE CITY -   November 23, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on

RNS Number : 8806T Renalytix PLC 17 November 2023     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2023 and Notice of 2023 Annual General Meeting   LONDON and SALT LAKE CITY, UT November, 17 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual

RNS Number : 3099T Renalytix PLC 14 November 2023   Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024   LONDON and SALT LAKE CITY , November 14, 2023   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial

RNS Number : 5522S Renalytix PLC 07 November 2023     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14   LONDON and SALT LAKE CITY , November 7, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it

RNS Number : 7470R Renalytix PLC 30 October 2023     Renalytix plc ("Renalytix" or the "Company")   Announcement of AGM and Publication of Annual Report 2023   LONDON and SALT LAKE CITY, UT   October 30, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that its Annual General Meeting